iNtRON Biotechnology

iNtRON Bio Co., Ltd. has been concentrating on continuous R&D investment since its inception. Since its listing on the KOSDAQ, we have been accelerating the scale and speed of our investment. Our company pursues the direction of "global R&D group." In addition to developing a number of 'first-in-class' biopharmaceutical pipelines. By gradually introducing various pipelines into domestic and overseas clinical trials. We will gradually increase the value as a biopharmaceutical company.